The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid
meeting on 12 November 2025.
All proposals on the agenda were adopted, cf. the notification of the
Extraordinary General Meeting that was published on Oslo Stock Exchange on 22
October 2025. The complete minutes of the Extraordinary General Meeting are
attached and are also available on https://lifecare.no/investor/governance/
About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring systems to market. Lifecare
enables osmotic pressure as sensing principle. Lifecare's sensor technology is
suitable for identifying and monitoring the occurrence of a wide range of
analytes and molecules in the human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40
Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42
This information is subject to disclosure under the Norwegian Securities
Trading Act, ยง5-12. The information was submitted for publication at
2025-11-12 20:34 CET.